Shuping Li Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2023	EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.
1/2022	Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer.
1/2020	Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors.
10/2013	Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance.
5/2011	Angiogenin as a molecular target for the treatment of prostate cancer.
3/2009	Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuping Li Research Topics

Disease

26	Neoplasms (Cancer) 02/2023 - 01/2010
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 06/2014
6	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 03/2009
6	Infections 06/2019 - 01/2008
4	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2018
4	Lung Neoplasms (Lung Cancer) 01/2023 - 12/2019
4	Liver Neoplasms (Liver Cancer) 01/2020 - 02/2019
3	Hypertension (High Blood Pressure) 01/2023 - 05/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 09/2018
3	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2016
3	Tremor (Tremors) 11/2020 - 04/2019
3	Memory Disorders (Memory Loss) 10/2019 - 05/2017
3	Parkinson Disease (Parkinson's Disease) 09/2019 - 01/2017
3	Cough 06/2019 - 03/2015
2	Neuroinflammatory Diseases 05/2024 - 10/2019
2	Sepsis (Septicemia) 01/2024 - 08/2015
2	Pain (Aches) 09/2023 - 01/2016
2	Hyperthermia 01/2023 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2012
2	Inflammation (Inflammations) 01/2022 - 12/2021
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2012
2	Cognitive Dysfunction 10/2019 - 05/2017
2	Asthma (Bronchial Asthma) 06/2019 - 05/2017
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2012
1	Hemorrhage 05/2024
1	Hypertensive Intracranial Hemorrhage 05/2024
1	Kidney Calculi (Kidney Stone) 09/2023
1	Breast Neoplasms (Breast Cancer) 02/2023
1	Flatulence 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Vitamin D Deficiency 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Night Blindness (Nyctalopia) 07/2022
1	Headache (Headaches) 07/2022
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 03/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
8	angiogeninIBA 01/2022 - 03/2009
7	AlkaloidsIBA 01/2021 - 03/2015
5	CytokinesIBA 01/2020 - 11/2011
4	Biomarkers (Surrogate Marker)IBA 02/2023 - 10/2019
4	EnzymesIBA 03/2022 - 01/2014
4	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2011
4	Ribonucleases (Ribonuclease)IBA 01/2022 - 01/2010
3	Monoclonal AntibodiesIBA 01/2022 - 05/2011
3	HarmalineIBA 01/2021 - 05/2017
3	Carbolines (Beta-Carbolines)IBA 01/2021 - 01/2017
3	Harmine (Telepathine)IBA 01/2021 - 05/2017
3	Messenger RNA (mRNA)IBA 12/2019 - 11/2011
3	Scopolamine (Hyoscine)FDA Link 10/2019 - 05/2017
2	Circular RNAIBA 05/2024 - 12/2021
2	VaccinesIBA 01/2023 - 01/2012
2	ribonuclease 4IBA 01/2022 - 04/2013
2	Propofol (Diprivan)FDA LinkGeneric 01/2022 - 01/2016
2	oxidized low density lipoproteinIBA 01/2022 - 01/2012
2	LipopolysaccharidesIBA 01/2022 - 12/2021
2	LigandsIBA 01/2022 - 02/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020 - 10/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 02/2019
2	ButyrylcholinesteraseIBA 10/2019 - 06/2014
2	AcetylcholinesteraseIBA 10/2019 - 06/2014
2	Therapeutic UsesIBA 10/2019 - 01/2012
2	Monoamine Oxidase (MAO)IBA 09/2019 - 05/2017
2	Ribosomal RNAIBA 10/2013 - 05/2011
2	Ribosomal DNA (rDNA)IBA 10/2013 - 05/2011
2	Antiviral Agents (Antivirals)IBA 11/2011 - 01/2008
2	AntigensIBA 02/2008 - 01/2008
1	tozasertibIBA 01/2024
1	Uric Acid (Urate)IBA 09/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Serum AlbuminIBA 01/2023
1	Proprotein Convertase 9IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	TetraspaninsIBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	TCVSIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	RezafunginIBA 01/2023
1	IntegrinsIBA 10/2022
1	arginyl-glycyl-aspartic acidIBA 10/2022
1	Peptides (Polypeptides)IBA 10/2022
1	TabletsIBA 07/2022
1	trans-crotonin (CTN)IBA 04/2022
1	C-Reactive ProteinIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022

Therapy/Procedure

8	Therapeutics 12/2023 - 10/2013
4	Immunotherapy 02/2023 - 10/2022
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
2	Adjuvant Chemotherapy 01/2023 - 01/2020
2	Traditional Medicine (Folk Remedies) 06/2019 - 03/2015
1	Radiofrequency Ablation 12/2023
1	Gastrectomy 01/2023
1	Lasers (Laser) 01/2023
1	Length of Stay 01/2023